Development and novel therapeutics in hepatocellular carcinoma: a review

This review summarizes the epidemiological trend, risk factors, prevention strategies such as vaccination, staging, current novel therapeutics, including the drugs under clinical trials, and future therapeutic trends for hepatocellular carcinoma (HCC). As HCC is the third most common cause of cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Ingle, Pravinkumar Vishwanath, Samsudin, Sarah Zakiah, Chan, Pei Qi, Ng, Mei Kei, Heng, Li Xuan, Yap, Siu Ching, Chai, Amy Siaw Hui, Wong, Audrey San Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801152/
https://www.ncbi.nlm.nih.gov/pubmed/27042086
http://dx.doi.org/10.2147/TCRM.S92377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801152/
https://www.ncbi.nlm.nih.gov/pubmed/27042086
http://dx.doi.org/10.2147/TCRM.S92377

Ejemplares similares